Enterprise Pharma Risk Analysis Implementation Case Study

This case study details the implementation of ThreatConnect Risk Quantifier (RQ) by a global pharmaceutical organization to enhance their cyber risk analysis processes. The organization faced challenges with their previous custom software system, which was not scalable and required extensive training. The decision to adopt ThreatConnect RQ was influenced by its flexibility in analysis methods and its ability to integrate with industry-standard frameworks such as NIST CSF and CIS Top 20. The implementation process was efficient, allowing the analyst team to utilize the tool immediately after training. Significant benefits were observed, including a reduction in turnaround time for risk analyses from four weeks to as little as one day. The organization plans to expand the use of ThreatConnect RQ to other teams, such as IT Risk and internal audit, to further enhance their cybersecurity controls and risk analysis capabilities. The case study outlines the advantages of ThreatConnect RQ over competitors, emphasizing its ability to provide comprehensive risk analysis and improve collaboration across the organization.